Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06739616 · ClinicalTrials.gov registry record · NA
Expanding Interventions for Automatically Maintained SIB
A NA study of Autism Spectrum Disorder and Intellectual Disability, sponsored by University of Georgia.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT06739616: Completed NA study of Autism Spectrum Disorder and Intellectual Disability, sponsored by University of Georgia.
NCT06739616 is a NA study of Autism Spectrum Disorder and Intellectual Disability that has completed, run by University of Georgia. The registered enrollment target is 7 participants, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06739616, a NA study of Autism Spectrum Disorder and Intellectual Disability, has completed, sponsored by University of Georgia.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to demonstrate feasibility of procedures and compare the outcomes of intervention arrangements to reduce sensory based self-injurious behavior exhibited by individuals with intellectual and developmental disabilities. The main question\[s\] it aims to answer are: (1) Demonstrate ability to meet enrollment requirements. (2) Evaluate acceptability and feasibility of participation relative to observation length and study duration. (3) Track and compare participant progress across interventions. (4) Demonstrate acceptable procedural fidelity and interobserver agreement. And (5) conduct post hoc evaluation of clinical presentation and intervention match. Participants will \[describe the main tasks participants will be asked to do, treatments they'll be given and use bullets if it is more than 2 items\]. If there is a comparison group: Researchers will compare \[insert groups\] to see if \[insert effects\].
Primary Outcome
Behavior that causes or has potential to cause injury to the participant
Conditions Studied
Interventions
- BEHAVIORAL AUTOSIB across time
- BEHAVIORAL AUTOSIB diminished reinforcement
Study Locations (1)
Massachusetts
- May Institute - Randolph
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2023-04-18 |
| Est. Completion | 2024-08-31 |
| Phase | NA |
What the finished NCT06739616 record still lists
NCT06739616 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 7 participants, a relatively small participant target, below the 135-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (95% lower).
The record links to 5 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 2 interventions - of which AUTOSIB across time is the first listed.
NCT06739616 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06739616 about?
NCT06739616 is a clinical study titled "Expanding Interventions for Automatically Maintained SIB". The goal of this clinical trial is to demonstrate feasibility of procedures and compare the outcomes of intervention arrangements to reduce sensory based self-injurious behavior exhibited by individuals with intellectual and developmental disabilities. The main question\[s\] it aims to answer are: ...
What is the current status of trial NCT06739616?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2023-04-18. Estimated completion is 2024-08-31.
What conditions does trial NCT06739616 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Intellectual Disability, Self Injurious Behavior, Problem Behavior, Restricted Behavior.
What interventions are being tested in trial NCT06739616?
The interventions under investigation include: AUTOSIB across time (BEHAVIORAL), AUTOSIB diminished reinforcement (BEHAVIORAL).
Who is sponsoring clinical trial NCT06739616?
This trial is sponsored by University of Georgia, which has 59 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06739616 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06739616's enrollment target sits among peer trials
7 224th of 224 higher than 1 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
-
Online Pivotal Response Treatment Training in Autism Spectrum Disorder
RECRUITING · NA
-
Cerebellum and Autism: Regional Specialization for Social and Executive Functions
RECRUITING · NA
-
Milieu Teaching-AV (MT-AV Pilot)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI